Prime Medicine, Inc. Common Stock (PRME) Ownership

16.16 ↓1.23 (-7.05%)
As of December 5, 2022, 12:38pm EST.

Institutional Ownership

There are no institutional owners of Prime Medicine, Inc. Common Stock (PRME).

Institution Ownership Chart

No institutional data found.

Latest Institutional Ownership Changes

No institutional ownership data for PRME.

Top Institutions

There are no institutional holders.

Mutual Fund Ownership

ARK Genomic Revolution ETF is the biggest individual fund holder of Prime Medicine, Inc. Common Stock (PRME), owning a total of 1.3 million shares. Combined, the top 19 mutual fund holders of PRME own 2.93% of the company with a total of 2.8 million shares.

In the latest ownership report on October 31st 2022, the top 19 fund holders increased their combined ownership of PRME by 1.5 million shares. 16 funds bought 1,506,046 total additional shares and increased their ownership by an average of 0.00%. However 1 funds sold 1,800 total shares and decreased their ownership by an average of 0.14%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding Prime Medicine, Inc. Common Stock increased by a net total of 1,504,246 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
ARK Genomic Revolution ETF1.313%-0.143%1,256,473-1,8002022-10-31
BlackRock Health Sciences Trust II0.431%0.000%412,139412,1392022-10-31
BlackRock Health Sciences Opps Inv A0.377%0.000%360,982360,9822022-10-31
Vanguard Total Stock Mkt Idx Inv0.300%0.000%287,205287,2052022-10-31
Vanguard Small Cap Index0.257%0.000%246,249246,2492022-10-31
Vanguard Small Cap Value Index Inv0.088%0.000%84,51184,5112022-10-31
Vanguard Small Cap Growth Index Inv0.075%0.000%71,62771,6272022-10-31
TrueShares Tech, AI and Deep Lrng ETF0.046%0.000%43,60402022-10-31
Pacific Select Health Sciences I0.017%0.000%16,50216,5022022-10-31
Vanguard Extended Market Index Investor0.009%0.000%8,7848,7842022-10-31
Vanguard Balanced Index Inv0.008%0.000%7,3427,3422022-10-31
Emerge ARK Genomics & Biotech ETF0.007%0.000%7,0507,0502022-10-31
Vanguard Russell 2000 ETF0.002%0.000%1,5221,5222022-10-31
BlackRock Future Health ETF0.001%0.000%1,05602022-10-31
Legal & General Russell 2000 CIT A0.001%0.000%1,0001,0002022-10-31
Vanguard Instl Ttl Stk Mkt Idx InstlPls0.001%0.000%4734732022-10-31
Vanguard Russell 2000 Growth ETF0.000%0.000%2642642022-10-31
Vanguard U.S. Eq Idx £ Acc0.000%0.000%2642642022-10-31
Vanguard Russell 2000 Value ETF0.000%0.000%1321322022-10-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
ARK Genomic Revolution ETF1.313%-0.143%1,256,473-1,8002022-10-31
BlackRock Health Sciences Trust II0.431%0.000%412,139412,1392022-10-31
BlackRock Health Sciences Opps Inv A0.377%0.000%360,982360,9822022-10-31
Vanguard Total Stock Mkt Idx Inv0.300%0.000%287,205287,2052022-10-31
Vanguard Small Cap Index0.257%0.000%246,249246,2492022-10-31
Vanguard Small Cap Value Index Inv0.088%0.000%84,51184,5112022-10-31
Vanguard Small Cap Growth Index Inv0.075%0.000%71,62771,6272022-10-31
TrueShares Tech, AI and Deep Lrng ETF0.046%0.000%43,60402022-10-31
Pacific Select Health Sciences I0.017%0.000%16,50216,5022022-10-31
Vanguard Extended Market Index Investor0.009%0.000%8,7848,7842022-10-31
Vanguard Balanced Index Inv0.008%0.000%7,3427,3422022-10-31
Emerge ARK Genomics & Biotech ETF0.007%0.000%7,0507,0502022-10-31
Vanguard Russell 2000 ETF0.002%0.000%1,5221,5222022-10-31
BlackRock Future Health ETF0.001%0.000%1,05602022-10-31
Legal & General Russell 2000 CIT A0.001%0.000%1,0001,0002022-10-31
Vanguard Instl Ttl Stk Mkt Idx InstlPls0.001%0.000%4734732022-10-31
Vanguard Russell 2000 Growth ETF0.000%0.000%2642642022-10-31
Vanguard U.S. Eq Idx £ Acc0.000%0.000%2642642022-10-31
Vanguard Russell 2000 Value ETF0.000%0.000%1321322022-10-31

Discussions

Please log in or register to share your thoughts.

timetogainmuneh

$PRME all’s I know is buy and hold… no expectations

0 Like Report